Launching the OSIC Data Repository has been a collaboration in its truest sense. By bringing together the world’s “best in class,” we’ve been able to build something truly remarkable – the largest and most diverse global database for rare fibrotic lung diseases. All open source. All for the benefit of patients.
We spoke with OSIC Board Member Eric S. White, MD, MS, senior clinical program lead, ILD, at Boehringer Ingelheim, and asked him what accomplishment within OSIC he is most proud of so far.
“Our team’s ability to put the patient first,” he answered. “OSIC is comprised of members from academia, the pharmaceutical and device industries, and patient advocacy groups around the world. Assembling this group with a sole focus on improving our ability to take care of patients is truly astounding!
OSIC pulmonology, radiology and artificial intelligence experts all share the same common goal – helping patients by working together to speed diagnosis, aid prognosis, and ultimately allow doctors to treat patients more efficiently and effectively.
“One of the many strengths of OSIC is the dedication of its participants to advance the science and improve patient care,” continued Dr. White. “The challenges put forth leverage crowd-sourcing to harness the strength of investigative teams everywhere who might not have previously applied their knowledge to ILD imaging. The ‘Open Source’ nature of OSIC means that investigators benefit from the efforts of everyone else in an open and transparent manner. We believe this will push science further and faster.”